Monday, December 30, 2019

AstraZeneca, Merck score win with Lynparza approval for pancreatic cancer

AstraZeneca, Merck score win with Lynparza approval for pancreatic cancer The drug is now the only approved medicine in biomarker-selected patients with advanced pancreatic cancer.

from Moneycontrol Business News https://ift.tt/35awRrv

No comments:

Post a Comment

Madhu Kela picks up stake in this stock market proxy player in Q3

Veteran investor Madhu Kela has bought a stake in Emkay Global. This signals new interest in the financial services firm. Ace investor Dolly...